Bioactive Material Market to Mark a Highest CAGR of 14.0% Through 2028

 

Bioactive Materials Market Growth & Trends

The global bioactive materials market size is estimated to reach USD 5.85 billion by 2028 registering a CAGR of 14.0% over the forecast period, according to a new report by Grand View Research Inc. Growing geriatric population coupled with the advancement in various surgical procedures is expected to drive the product demand in the market. Rising consumer awareness about health and well-being is projected to drive market growth during the forecast period.

The product helps in promoting stem cell structure and the transplanted stem cells offer enhanced therapeutic effects in surgeries. Thus, a wide scope of application for these products in the replacement and reconstruction of damaged cells, tissues, and bones is fueling the product demand in the surgery application sector. Moreover, increasing technological advancements coupled with the growing demand for dental care and orthopedics, due to high awareness about oral health & hygiene, are also supporting market growth.

The availability of favorable healthcare policies and fast-curing surgical & low-cost post-implant procedures in various developed regions including, the U.S., Japan, France, and others, are offering positive growth prospects to the overall market. Some of the key applications of the product include dentistry, surgery, bioengineering, and others.

Request a free sample copy or view report summary: Bioactive Materials Market Report

Bioactive Materials Market Report Highlights

• The glass material segment is expected to register the fastest CAGR of 14.8% over the forecast period
• This growth is credited to high demand for glass materials owing to their nonporous and solid characteristics, which are suited for stimulation of bone growth and various surgical procedures
• In 2020, dentistry emerged as the largest application segment with a share of 46.0% and is likely to ascend at a significant CAGR during the forecast period
• Growing cases of oral health problems including cancer and gum problems are driving the product demand in the dentistry application segment
• In 2020, North America emerged as the largest regional market owing to the increased number of dental procedures performed, such as tooth regeneration, root canal, bone-defect treatment, and various related surgeries
• In Europe, the revenue for the powder type segment was valued at USD 157.9 million in 2020 and is anticipated to gain higher shares in the forecast period on account of rising demand from the dentistry, bioengineering, and surgery application industries
• Asia Pacific is estimated to be the fastest-growing regional market during the forecast period on account of increasing product consumption as a result of rising health problems and growing population in emerging economies like China and India
• Prominent players in the market have undertaken various initiatives, such as advancing healthcare infrastructure, partnership, and scientific research in collaboration with healthcare institutions
• Moreover, government support and policies within the respective countries are expected to influence the market on a positive note

Access Press Release@ https://www.grandviewresearch.com/press-release/global-bioactive-materials-market

Bioactive Materials Market Segmentation

Grand View Research has segmented the global bioactive materials market on the basis of material, type, application, and region:

Bioactive Materials Outlook (Revenue, USD Million, 2017 - 2028)

• Glass
• Glass-ceramic
• Composite
• Others

Bioactive Materials Type Outlook (Revenue, USD Million, 2017 - 2028)

• Powder
• Moldable
• Granules
• Others

Bioactive Materials Application Outlook (Revenue, USD Million, 2017 - 2028)

• Dentistry
• Surgery
• Bioengineering
• Others

Bioactive Materials Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
• Middle East & Africa

List of Key Players of Bioactive Materials Market

• Zimmer Holding Inc.
• Medtronic Inc.
• Stryker Corporation
• DePuy Synthes
• Biomatlante
• Arthrex, Inc.
• Pulpdent Corporation
• Bioactive Bone Substitutes Oy
• Lasak s.r.o
• Bioretec Ltd.
• Noraker
• Septodont Holding
• I. TAKIRON Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nicotine Replacement Therapy Market Estimated to Experience a Hike in Growth by 2028

 Nicotine Replacement Therapy Market Growth & Trends

The global nicotine replacement therapy market size is expected to reach USD 147.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.3% from 2021 to 2028. The growth of the market is largely attributed to increasing government initiatives to promote nicotine replacement therapy (NRT) products for reducing mortality due to smoking and diseases associated with it.

Smoking cessation campaigns are also playing a crucial role in increasing awareness about diseases that are caused because of smoking. These campaigns are run by regional governments as well as multinational companies, such as Philip Morris International and Altria. Global organizations like the WHO are also working toward creating awareness by running online campaigns. 

There has been an exponential increase in the usage of NRT products. The young population is the largest consumer of advanced NRT products, like heat-not-burn tobacco and e-cigarettes. However, middle-aged patients’ interest in smoking cessation has led to a rise in the usage of e-cigarettes. For instance, the use of e-cigarettes for smoking cessation increased to 20% in 2018 from 13% in 2016 among people aged 45 to 54 years.

Furthermore, researchers found that 5% to 9% of smokers tend to use nicotine patches even after the therapeutic period of 12 weeks. The passive approach of combining nicotine patches with a gum, inhaler, or spray is found to be more effective, and quitting rate reaching 34% to 54%. NRT is only recognized as a way of curbing nicotine cravings and treatment by consumers.

With technological advancements, the players in this market are also developing products to suit the changing consumer preferences. For instance, the e-cigarette market is changing with newer innovations that are more efficient, have longer battery life, and are rechargeable. The existing innovations like sleek and easy-to-use socially acceptable e-cigarettes brought a revolution, which drove more people to shift to using NRTs without social stigma.

Various players such as Nicocigs Ltd.; Nicoventures Ltd.; Victory Electronic Cigarettes Corp.; DuraSmoke; AlternaCig; Shenzhen IVPS Technology CO. Limited; and Vapor Group, Inc. are launching e-cigarettes and related products. Although there are hundreds of companies selling e-cigarettes, their usage in NRT is disputed.

Request a free sample copy or view report summary: Nicotine Replacement Therapy Market Report

Nicotine Replacement Therapy Market Report Highlights

• By product, the e-cigarettes segment held the largest NRT market share in 2020 due to increasing investments and the rising focus of companies on developing value-added products. The heat-not-burn tobacco products segment is expected to grow at the fastest rate over the forecast period
• The offline distribution channel segment dominated the market in 2020. Retail chains across the world are investing in advanced technologies and undertaking new initiatives in order to improve sales and attract more customers. The increasing sales of e-cigarettes through vape shops and retail stores is another factor augmenting the growth of this segment
• Asia Pacific held the largest market share in 2020. Favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products, are supporting continual growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nicotine-replacement-therapy-market

Nicotine Replacement Therapy Market Segmentation

Grand View Research has segmented the global nicotine replacement therapy market by product, distribution channel, and region:

NRT Product Outlook (Revenue, USD Billion, 2017 - 2028)

• Nicotine Replacement Therapy
  • Inhalers
  • Gum
  • Transdermal Patches
  • Sublingual Tablets
  • Lozenges
  • Others
• E-cigarettes
• Heat-not-burn Tobacco Products

NRT Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2028)

• Offline
• Online

NRT Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Nicotine Replacement Therapy Market

• Philip Morris Products S.A. (Altria Group)
• British American Tobacco p.l.c.
• Japan Tobacco, Inc.
• Imperial Brands
• Glenmark
• Fertin Pharma
• Cipla Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gene Delivery Technologies Market is Anticipated To Generate Significant Revenues by 2028: Grand View Research Inc.

 Gene Delivery Technologies Market Growth & Trends

The global gene delivery technologies market size is expected to reach USD 7.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.1% from 2021 to 2028. Technological advancements in viral vectors, a growing pipeline of advanced therapies, and a rising number of regulatory approvals for advance therapy products are some key driving forces of the market.

Several novel tools are being introduced for genetic alterations that have facilitated the scientific community to delineate the disease intricacies at the genomic level, leading to the emergence of novel gene delivery approaches. Furthermore, ongoing research to develop clinically relevant vectors including viral and non-viral vectors to combat chronic illnesses such as cancer, Alzheimer’s, and others through advanced therapies is spurring the market revenue.

An increase in investment and financing in the space to support the research, development, and manufacturing of various modes of gene transfer further accelerates the revenue growth. Currently, around 70% of gene and cell therapy programs are based on viral vectors leading to organic revenue growth for biological delivery technologies. The operating players are investing significantly to scale up their viral vector manufacturing capability and meet the growing demand.

Considering growing opportunities in physio-chemical gene delivery approaches, key players are making focused efforts to boost their business presence. For instance, nanoparticles have proven their efficiency as promising vehicles for clinical usage owing to their tunable morphology, and biological behaviors. Such ongoing developments in the space are anticipated to accelerate revenue growth in this market in the coming years.

Request a free sample copy or view report summary: Gene Delivery Technologies Market Report

Gene Delivery Technologies Market Report Highlights

• The wide implementation of biological gene delivery technologies in clinical usage owing to their high efficiency and specificity has resulted in the segment’s largest revenue share in 2020
• Gene therapy development is the key revenue-generating application in the 2020 market owing to constantly expanding pipeline programs of therapies against life-threatening conditions coupled with the recent success of CAR-T therapies
• The recent pandemic of SARS-CoV-2 has also resulted in substantial global investments in R&D of viral vector-based vaccine to combat the virus, resulting in lucrative growth of this segment
• The ex vivo method accounted for the major revenue share owing to its advantages such as high transduction efficiency and less immunogenic responses
• However, both in vivo and ex vivo have shown clinical success in the treatment of chronic conditions, thus both segments are expected to witness lucrative growth in the coming years
• Given the high number of biotech companies and a favorable regulatory environment in the U.S.; North America dominated the global market in terms of revenue
• On the other hand, Asia Pacific is projected to grow at the fastest pace during the forecast period
• Constantly evolving CDMO and viral vector manufacturing landscapes through plant expansions and new sites being built across the Asian countries is spurring the adoption of vectors in this region
• The key players are engaged in collaboration with therapy developers to support their product development process

Access Press Release@ https://www.grandviewresearch.com/press-release/global-gene-delivery-technologies-market

Gene Delivery Technologies Market Segmentation

Grand View Research has segmented the global gene delivery technologies market on the basis of mode, application, method, and region:

Gene Delivery Technologies Mode Outlook (Revenue, USD Million, 2017 - 2028)

• Biological
  • Adenovirus
  • Retrovirus
  • AAV
  • Lentivirus
  • Other viruses
  • Non-viral
• Chemical
• Physical

Gene Delivery Technologies Application Outlook (Revenue, USD Million, 2017 - 2028)

• Gene Therapy
• Cell Therapy
• Vaccines
• Research

Gene Delivery Technologies Method Outlook (Revenue, USD Million, 2017 - 2028)

• Ex vivo
• In vivo
• In vitro

Gene Delivery Technologies Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players in Gene Delivery Technologies Market

• Thermo Fisher Scientific, Inc.
• QIAGEN
• Horizon Discovery Group Co.
• OriGene Technologies, Inc.
• Oxford Biomedica
• SignaGen Laboratories
• Vectalys
• Takara Bio Inc.
• Bio-Rad Laboratories, Inc.
• System Biosciences llc
• Promega Corporation
• Hoffmann-La Roche AG
• Sirion-Biotech GmbH
• Catalent Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Virtual Reality Market Competitive Insight and Key Drivers During the Forecast Period

 

Virtual Reality Market Growth & Trends

The global virtual reality market size is anticipated to reach USD 69.60 billion by 2028, according to the latest report by Grand View Research, Inc. The market is expected to record a CAGR of 18.0% from 2021 to 2028. Technological advancements in the past years have made it feasible to experience real-world life in a digitally immersive environment with Virtual Reality (VR) and Augmented Reality (AR). The Covid-19 pandemic has given a rapid rise to VR-enabled platforms and tools, especially in the education and e-commerce sectors. VR technology has offered many companies new techniques and opportunities to attract potential customers to their business.

The e-commerce industry offers the unique feature of virtually trying clothes or accessories and assisting customers in making the right purchase decisions. Moreover, the temporary shutdown of educational institutions to curb the spread of coronavirus has compelled institutions to shift their academic sessions to VR-based online platforms for better collaboration. The technology has also enabled medical professionals to provide training and aid treatments through its audio-visual tool. The major drivers of the global market are the increasing adoption of automation and Artificial Intelligence (AI) across several industries.

The commencement of 5G network bandwidth that is expected to enhance the immersion experience on VR devices and the rise in smartphone penetration is also likely to boost the market growth. Various industries, such as healthcare, retail, education, manufacturing, automation, real estate, and tourism, have deployed several VR-based software/devices that have proven beneficial for their businesses. For instance, Atlantis, The Palm Dubai, a luxury resort in the UAE, offers its potential customers the opportunity to experience the ambiance of the resort through a VR 360 tool, providing an immersive and real-like sight to the viewers.

Request a free sample copy or view report summary: Virtual Reality Market Report

Virtual Reality Market Report Highlights

• Innovations in smartphone hardware, coupled with state-of-the-art VR-compatible headsets, are anticipated to drive the market from 2021 to 2028
• The Head-Mounted Display (HMD) segment accounted for over 60.0% of the total market share in 2020
• The semi & fully immersive technology segment accounted for the largest revenue share in 2020 and is expected to witness substantial growth over the forecast period
• This growth is attributed to the ability of the technology to provide real-like dimension to a simulated realm
• In 2020, Asia Pacific accounted for the largest market share of around 40.0% and is expected to maintain its lead throughout the forecast years

Virtual Reality Market Segmentation

Grand View Research has segmented the global virtual reality market on the basis of device, technology, component, application, and region:

VR Device Outlook (Revenue, USD Million, 2016 - 2028)

• Head-Mounted Display (HMD)
• Gesture-Tracking Device (GTD)
• Projectors & Display Wall (PDW)

VR Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Semi & Fully Immersive
• Non-Immersive

VR Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware
• Software

VR Application Outlook (Revenue, USD Million, 2016 - 2028)

• Aerospace & Defense
• Consumer
• Commercial
• Enterprise
• Healthcare
• Others

VR Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • Japan
  • India
• South America
  • Brazil
• Middle East & Africa (MEA)

List of Key Players of Virtual Reality (VR) Market

• Barco
• CyberGlove Systems, Inc.
• Facebook Technologies, LLC
• HTC Corporation
• Microsoft
• Samsung Electronics Co., Ltd.
• Sensics, Inc.
• Sixense Enterprises, Inc.
• Ultraleap Ltd.

Access Press Release of Virtual Reality Market@ https://www.grandviewresearch.com/press-release/global-virtual-reality-vr-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Aviation IoT Market Poised to Expand at a Robust Pace Over 2028

 Aviation IoT Market Growth & Trends

The global aviation IoT market size is anticipated to reach USD 22.51 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 21.4% from 2021 to 2028. The aviation industry is tectonically shifting toward automated and intelligent systems in line with the continued advances in technology. At this juncture, IoT (internet of things) devices are emerging as crucial devices for the incumbents of the aviation industry to gather real-time data and derive actionable insights.

The aviation industry is continuously adopting a digital ecosystem and is subsequently set to generate large volumes of data. The development of a more recent version of the Internet Protocol (IP), Internet Protocol version 6 (IPv6), has already improved the data handling capability and the overall functionality. The introduction of low-power terrestrial networks in L-band to support 5G connectivity is expected to further enhance the data transfer capacity, thereby encouraging the deployment of IoT-compatible devices in the aviation industry.

IoT is expected to play a critical role in weather forecasting as well as monitoring various systems of the aircraft in real-time. Monitoring the weather using advanced sensors and analyzing the gathered weather data can help airlines in making crucial decisions in real-time and choosing alternative flight routes. Similarly, deploying IoT sensors and devices inside the aircraft can help in monitoring engine performance and subsequently reducing fuel consumption and improving the profit margins.

Request a free sample copy or view report summary: Aviation IoT Market Report

Aviation IoT Market Report Highlights

• Enhancement of passenger experience and modernization of the existing airport infrastructure are expected to be the crucial factors responsible for the surging deployment of IoT-compatible solutions across the aerospace industry
• Development of an advanced Aircraft Health Monitoring System (AHMS) for monitoring aircraft operation helps predict maintenance and identify the failure of components in advance to reduce the risks and downtime of aircraft maintenance
• Key airline operators are utilizing cloud computing technology to store the large volumes of data generated from numerous sensors, thereby opening opportunities for intercontinental airline operators to analyze the data for deriving insights
• IoT-enabled aircraft cabins can potentially offer personalized entertainment content and some of the prime airline operators have already adopted such IFE modules to increase passenger loyalty and enhance ancillary revenues

Access Press Release@ https://www.grandviewresearch.com/press-release/global-aviation-internet-of-things-market

Aviation IoT Market Segmentation

Grand View Research has segmented the global aviation IoT market by application, end-use, and region:

Aviation IoT Application Outlook (Revenue, USD Million, 2016 - 2028)

• Ground Operations
• Passenger Experience
• Aircraft Operations
• Asset Management

Aviation IoT End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Airport
• Airline Operators
• MRO
• Aircraft OEM

Aviation IoT Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
• Latin America
• Middle East & Africa (MEA)

List of Key Players of Aviation IoT Market

• Honeywell International, Inc.
• Tata Communication
• Cisco Systems, Inc.
• Huawei Technologies Co. Ltd.
• SITAONAIR

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

DNA & RNA Banking Services Market Poised to Expand at a Robust Pace Over 2027: Grand View Research Inc.

 DNA & RNA Banking Services Market Growth & Trends

The global DNA and RNA banking services market size is expected to reach USD 8.83 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.46% from 2021 to 2027. Biospecimens such as DNA and RNA are critical for biomarker discovery, thereby providing a path for the expansion of personalized medicine. Moreover, progress in translational and clinical research through an introduction of advanced, standardized cell isolation methodologies reduces hands-on-time. The development of automated solutions and the transformation of biobanks into fully automated biobanks potentially accelerate the growth of the market.

A rise in the enrollment of individuals for personalized medicine initiatives drives the revenue generation for DNA and RNA banking services. In July 2019, Partners HealthCare, U.S. enrolled more than 100,000 individuals in its precision medicine biobank that supported clinicians and researchers of the Brigham and Women’s Hospital, U.S., and other partners. Such initiative assisted in examining the impact of several factors on disease and health.

The distribution network is continuously becoming complex, with pharmaceutical firms facing new challenges related to sustainability initiatives, regulatory adherence, and competing priorities cost pressures. The efforts undertaken by the key players to invest in the cold chain storage and expansion of distribution capability in various geographies have increased the capability to handle large quantities of complex cold chain biologics. Key companies such as EasyDNA, DNA Genotek, 23andMe, GoodCell, ProteoGenex., and US Biolab have adopted several strategic alliances to reinforce their market presence. 

Request a free sample copy or view report summary: DNA & RNA Banking Services Market Report

DNA & RNA Banking Services Market Report Highlights

• By service type, storage services accounted for the largest revenue share in 2020 owing to the presence of numerous key providers in the market space. The advent of automated sample storage systems and automated liquid handlers to manage large sample volume, and reduce the amount of time required to process, store, and distribute samples further drives the segment
• Based on specimen type, the blood segment dominated the market in 2020 owing to fast and quick procedures of collecting blood, minimal risk of contamination, and visibility of blood samples
• In terms of application, the drug discovery and clinical research segment held the largest share in 2020. Biobanking services are utilized to accelerate the discovery of new therapeutics and offer resources for future investigations to better understand the effects of environmental, genetic, and lifestyle factors on human health, morbidity, and mortality. This factor led to the maximum revenue share of the segment
• On the basis of end use, the hospitals and diagnostic centers segment is projected to witness the fastest growth throughout the forecast period owing to the efforts undertaken by government bodies and biobanks to broaden the accessibility for DNA and RNA samples in the hospitals and diagnostic centers for COVID-19 diagnosis
• North America accounted for the largest revenue share in 2020. One of the major factors positively accelerating market growth is the initiation of national precision-medicine initiatives, such as the “All of Us” biobank in the U.S.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dna-rna-banking-services-market

DNA & RNA Banking Services Market Segmentation

Grand View Research has segmented the global DNA and RNA banking services market on the basis of service type, specimen type, application, end-use, and region:

DNA & RNA Banking Service Type Outlook (Revenue, USD Million, 2016 - 2027)

• Transportation Service
• Processing Service
• Storage Service
• Quality Control Service
• Data Storage
• Others

DNA & RNA Banking Services Specimen Type Outlook (Revenue, USD Million, 2016 - 2027)

• Blood
• Buccal Swabs & Hair Follicles
• Others

DNA & RNA Banking Services Application Outlook (Revenue, USD Million, 2016 - 2027)

• Therapeutics
• Drug Discovery & Clinical Research
• Clinical Diagnostics
• Other Applications

DNA & RNA Banking Services End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Academic Research
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Others

DNA & RNA Banking Services Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of DNA & RNA Banking Services Market

• EasyDNA
• DNA Genotek Inc.
• 23andMe, Inc.
• GoodCell
• US Biolab Corporation, Inc.
• Infinity Biologix
• Thermo Fisher Scientific, Inc.
• deCODE genetics
• Brooks Life Sciences
• LGC Biosearch Technologies
• PreventionGenetics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Digital Pathology Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

 North America Digital Pathology Market Growth & Trends          

The North America digital pathology market size is expected to reach USD 593.9 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.

The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past years. The increasing need for lowering healthcare costs, increasing importance of big data in healthcare, rising adoption of precision medicine, and declining hardware costs are some factors driving the growth. In addition, increasing usage of artificial intelligence-based analytical tools in healthcare and high capital investments in this field are further propelling the market growth.

During the coronavirus outbreak, the exponential need for home-based workstations and safe clinical informatics systems allowing healthcare professionals to read images remotely and enabling virtual collaboration between their multi-disciplinary care teams has increased. Various histopathology departments in the region faced a reducing workforce and increasing workload during the pandemic. Digital pathology considered being the potential solution for some of the challenges faced by the pathologist, there is an increase in the adoption of digital diagnosis of disease during coronavirus outbreak.

In April 2020, Philips announced that the FDA granted a waiver for home use of consumer monitors with the company's IntelliSite Pathology Solution during the emergency. The temporary exemption of restrictions on remote use of the digital pathology helps pathologists to access whole slide images from home and fasten the diagnosis of histology cases. Some pathology labs that have adopted DP in their workflows across different sites pre-COVID-19, reported improved collaboration, and an average productivity gain of 21.0% with operation efficiency increased by 13.0%. These types of initiatives are anticipated to fuel market growth.

Request a free sample copy or view report summary: North America Digital Pathology Market Report

North America Digital Pathology Market Report Highlights

• The software segment is anticipated to witness a lucrative growth rate of 6.8% in the coming years. The segment is inclusive of pathology workflow management solution and LIMS software
• This software is simple to install and use, easy to obtain specific patient information, and efficiently and quickly sends reports digitally to pathologists and clinicians. Owing to these associated advantages the software segment is expected to witness lucrative growth over the forecast period
• The practice of sharing digital imagery across labs helps in accelerating drug discovery and development processes by enabling pathologists to effectively analyze records and communicate and collaborate on crucial result findings in tissue-based efficacy studies
• The disease diagnosis segment is projected to witness a significant CAGR of 7.0% in the coming years as the FDA approved the practice of sharing digital imagery across labs for primary diagnosis applications such as cancer cell detection
• Diagnostic laboratories are expected to witness lucrative growth of 7.1% over the forecast period owing to the rising incidence of cancer in this region. Moreover, the implementation of digital pathology solutions and devices is likely to help improve laboratory workflow efficiency, accuracy, and quality of disease diagnosis using computational pathology
• Competitive rivalry in the market is expected to remain high over the forecast period. The market is dominated by few players such as Philips and Leica Biosystems that hold a majority of the revenue
• The strategies implemented by these players are product differentiation, new product launch, collaboration, merger, and acquisition to gain a larger share of the market

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-digital-pathology-market-analysis

North America Digital Pathology Market Segmentation

Grand View Research has segmented the North America digital pathology market on the basis of the product, application, end use, and country:

North America Digital Pathology Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Device

North America Digital Pathology Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Discovery & Development
• Academic Research
• Disease Diagnosis
  • Cancer Cell Detection
  • Others

North America Digital Pathology End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Cancer Hospitals
• Diagnostic Labs
• Academic & Research Institutes

North America Digital Pathology Country Outlook (Revenue, USD Million, 2016 - 2028)

• US.
• Canada

List of Key Players of North America Digital Pathology Market

• Leica Biosystems
• Hamamatsu Photonics, Inc.
• Koninklijke Philips N.V.
• Hoffmann-La Roche Ltd
• Mikroscan Technologies
• 3DHISTECH Ltd.
• Inspirata, Inc.
• Visiopharm A/S
• Huron Technologies International, Inc.
• Sectra AB

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Size Is Expected To Reach USD 2.3 Billion by 2027

 Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Growth & Trends

The global continuous manufacturing market in pharmaceuticals and biopharmaceuticals size is expected to reach USD 2.3 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 13.85% from 2021 to 2027. Although batch manufacturing is the dominant mode of product development within the pharma and biopharma industry, the companies have begun shifting their focus toward continuous manufacturing (CM). The key drivers for the transition from batch to continuous manufacturing include drug shortage, more stringent requirements for consistent quality, the need for reduced processing costs, and the demand for higher and improved productivity.

Regulatory authorities are increasingly supportive of this therapeutic development model. They are encouraging the adoption of CM through releasing drafts and guidelines. Moreover, the presence of communities and organizations that are devoted to the commercialization of this market within the pharma and biopharma sector is driving the revenue. CCP Summit 2020 is one of such summits that is engaged in exploring scientific and technological advancements to address the technology challenges and accelerate upfront investment in the market.

In addition, the growing demand for biosimilars and an ever-increasing pressure for reducing drug development costs have driven the interest of biopharma players in this space. With a plethora of research activities available on making individual unit operations continuous, studies are also conducted to explore the possibility of a continuous end-to-end development process. Ongoing research efforts in this area are anticipated to greatly favor the revenue growth in the coming years.

Based on mode, in-house pharmaceutical companies are anticipated to witness lucrative growth in the coming years owing to the shift of well-established pharma players toward the continuous manufacturing market. On the basis of scale, the clinical and preclinical scale manufacturing segments collectively captured a significant revenue share in 2020 owing to the easy integration of systems and a high number of ongoing R&D activities.

North America led the global market in 2020. This is attributed to the presence of key technology developers as well as high R&D expenditure in drug development by the end-users in the U.S. Key players are implementing various strategies to strengthen their product offerings and offer diverse technologically advanced products to accelerate therapeutics development.

Request a free sample copy or view report summary: Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Report

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Report Highlights

• In terms of therapeutics type, the pharmaceutical/small molecules segment dominated the market in 2020 owing to high technology penetration in this segment. The biopharmaceutical/large molecules segment is anticipated to witness lucrative growth owing to increasing investment in facility expansion to integrate CM systems
• On the basis of application, finished product manufacturing led the market in 2020 owing to the established use of CM in finished product development due to the commercial cost and time-saving advantages of technology
• By formulation, solid formulation dominated the market in 2020 owing to the maximum adoption of CM methodologies in solid drug production
• Based on mode, the contract segment led the market in 2020 due to the ongoing demand, coupled with the increasing popularity of contract services. The increasing investment in biosimilars production is expected to spur the use of CM technology within contract manufacturing organizations
• By product, semi-continuous systems accounted for the maximum revenue share in 2020 owing to the increasing adoption of a hybrid model of manufacturing within small to medium-sized drug developers as well as major pharma companies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-continuous-manufacturing-market-pharmaceuticals-biopharmaceuticals

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Segmentation

Grand View Research has segmented the global continuous manufacturing market in pharmaceuticals and biopharmaceuticals on the basis of therapeutics type, application, formulation, mode, scale, product, and region:

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Therapeutics Type Outlook (Revenue, USD Million, 2016 - 2027)

• Large Molecules
• Small Molecules

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Application Outlook (Revenue, USD Million, 2016 - 2027)

• Finished Product Manufacturing
• API Manufacturing

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Formulation Outlook (Revenue, USD Million, 2016 - 2027)

• Solid Formulation
• Liquid & Semi-solid Formulation

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Mode Outlook (Revenue, USD Million, 2016 - 2027)

• In-house
• Contract

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Scale Outlook (Revenue, USD Million, 2016 - 2027)

• Preclinical
• Clinical
• Commercial

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Product Outlook (Revenue, USD Million, 2016 - 2027)

• Integrated Systems
• Semi-continuous Systems
  • Continuous Granulators
  • Continuous Blenders
  • Continuous Compressors
  • Continuous Coaters
  • Continuous Dryers
  • Other Semi-continuous Systems
• Others

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Continuous Manufacturing Market in Pharmaceuticals & Biopharmaceuticals

• Thermo Fisher Scientific, Inc.
• Pall Corporation
• Applikon Biotechnology
• Sartorius Stedim Biotech
• GEA Group Aktiengesellschaft
• Corning Incorporated
• Merck KGaA
• Glatt GmbH
• Repligen Corporation
• Eppendorf AG
• Electrolab Biotech Ltd.
• Solesis Medical
• Scott Equipment Company
• B. Bohle
• LONZA
• 3M
• CellGenix GmbH
• Boehringer Ingelheim International GmbH
• Bio-Rad Laboratories
• Avantor, Inc.
• Ajinomoto Bio-Pharma
• GlaxoSmithKline
• Continuus Pharmaceuticals
• Arcinova
• Amgen

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand for Veterinary Active Pharmaceutical Ingredients Manufacturing Market to Incur Considerable Upsurge During 2021 – 2028

 Veterinary API Manufacturing Market Growth & Trends

The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.4 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.9% over the forecast period. The increasing prevalence of chronic diseases in animals and growing concerns among pet owners are the key contributors to the market growth.

Moreover, the growing prevalence of zoonotic diseases is driving the demand for drugs, which, in turn, boosts the demand for active pharmaceutical ingredients (APIs) for the production of these drugs. According to the Centers for Disease Control and Prevention (CDC), in July 2017, it was estimated that 6 out of 10 known infectious diseases in people can be transmitted from animals and 3 out of every 4 novel or emerging infectious diseases in people are caused due to animals.

Government organizations are involved in issuing various guidelines to promote veterinary services globally, which is expected to contribute to market growth in the coming years. For instance, in May 2018, the OIE International Standards, a part of the WTO framework, issued standards to improve animal health, which will affect human health as well. One of the key challenges was found to be the lack of technical expertise in this field.

The rising number of veterinarians is also anticipated to boost the market growth. According to the American Veterinary Medical Association, in 2018, there were 113,394 veterinarians in the U.S. as compared to 110,531 veterinarians in 2017. Out of these, 48,898 were involved in private clinical practice exclusively for companion animals. Also, according to the Canadian Veterinary Medical Association (CVMA), the approximate number of veterinarians in Canada is 12,921.

Request a free sample copy or view report summary: Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report

Veterinary API Manufacturing Market Report Highlights

• The contract outsourcing service type accounted for the largest revenue share of over 58% in 2020 owing to associated benefits with its usage
• The growing number of outsourcing activities by pharmaceutical companies is expected to boost the segment growth
• Chemical-based API synthesis type dominated the market in 2020. This can be attributed to its high usage by many major manufacturing companies
• The vaccines product segment held the largest market share of over 23% in 2020 due to increased demand for vaccines as a result of a high prevalence of chronic diseases in animals
• Due to the presence of well-established companies and technologically advanced infrastructure, North America dominated the market in 2020
• However, Asia Pacific is anticipated to register the fastest CAGR over the forecast period owing to the high potential and rapidly growing markets of India, Japan, and China
• Industry players are involved in strategies including mergers & acquisitions, collaborative agreements, and geographic expansions to gain a competitive edge
• For instance, in March 2020, SeQuent Scientific Ltd. received WHO-GENEVA approval for API Praziquantel, which is an anti-helminthic, under pre-qualification program in its Vizag, India facility

Access Press Release@ https://www.grandviewresearch.com/press-release/global-veterinary-active-pharmaceutical-ingredients-manufacturing-market

Veterinary API Manufacturing Market Segmentation

Grand View Research has segmented the global veterinary active pharmaceutical ingredients manufacturing market on the basis of service type, synthesis type, product, and region:

Veterinary API Manufacturing Service Type Outlook (Revenue, USD Million, 2016 - 2028)

• In House
• Contract Outsourcing
  • Contract Development
    • Preclinical Development
    • Others
  • Contract Manufacturing
    • API/Bulk Drugs
    • Finished Dose Formulations

Veterinary API Manufacturing Synthesis Type Outlook (Revenue, USD Million, 2016 - 2028)

• Chemical-based API
• Biological API
• HPAPI

Veterinary API Manufacturing Product Outlook (Revenue, USD Million, 2016 - 2028)

• Antiparasitic
• Anti-infectives
• NSAIDs
• Vaccines
• Biologics
• Others

Veterinary API Manufacturing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa

List of Key Players of Veterinary API Manufacturing Market

• Alivira Animal Health Ltd.
• Excel Industries Ltd.
• Ofichem Group
• Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
• Menadiona
• Afton Pharma
• Jiangsu Lingyun Pharmaceutical Co., Ltd.
• SUANFARMA
• NGL Fine-Chem Ltd.
• FIS - Fabbrica Italiana Sintetici S.p.A

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Frozen Dessert Market Overview, Analysis And Forecast To 2028

 U.S. Frozen Dessert Market Growth & Trends

The U.S. frozen dessert market size is expected to reach USD 82.00 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.7% from 2021 to 2028. The market is highly dynamic as a large number of international and domestic companies can be seen competing for their share. Players are continually innovating and experimenting with new ingredients and flavors to ensure there is something for everyone. One of the most popular consumer preference that has emerged as a significant trend in the industry is the demand for low-calorie and low-sugar options.

Growth in consumers’ awareness regarding eating healthy, staying fit, and avoiding weight gain is expected to drive the demand for low-calorie frozen novelties. Companies offering such products have been mentioning the calorie and nutritional content in large and clear fonts on the packaging to attract consumers in the near future.

Another popular trend in the market is the growth in demand for vegan products and a majority of manufacturers have been introducing vegan frozen novelty products. The demand for dairy-free products is no longer restricted to lactose-intolerant consumers but expands to those looking for variety or those following a special diet. This trend has resulted in the growing availability of non-dairy frozen novelties over the next few years.

Request a free sample copy or view report summary: U.S. Frozen Desserts Market Report

U.S. Frozen Dessert Market Report Highlights

• By product, the ice cream and gelato segment held the largest share of more than 40.0% in 2020. Product launches have been contributing immensely to the wide penetration of this product segment
• The water and fruit puree-based frozen desserts segment is anticipated to be the fastest-growing product segment with a CAGR of 13.0% from 2021 to 2028. Increasing focus on consuming plant-based organic food items is propelling the growth of the segment
• By type, the dairy segment accounted for the largest share of more than 80.0% in 2020. The category enjoys a wide penetration owing to the first-mover advantage
• The vegan type segment is anticipated to expand at the fastest CAGR of 11.3% from 2021 to 2028. The rising adoption of veganism in households is a major factor expected to contribute to the massive growth of the segment over the next few years
• New product launches have been contributing immensely to the wide penetration of the market. In May 2020, Ben & Jerry launched a new ice cream flavor called Boots on the Moooo'n, in partnership with Netflix

Access Press Release@ https://www.grandviewresearch.com/press-release/us-frozen-desserts-market-analysis

U.S. Frozen Dessert Market Segmentation

Grand View Research has segmented the U.S. frozen dessert market on the basis of product, type, and distribution channel:

U.S. Frozen Dessert Product Outlook (Revenue, USD Million, 2016 - 2028)

• Frozen Yogurt
• Ice Cream & Gelato
• Cake & Pastry
• Water & Fruit Puree Based Frozen Desserts
• Sweet, Chocolate & Candy
• Others

U.S. Frozen Dessert Type Outlook (Revenue, USD Million, 2016 - 2028)

• Vegan
• Dairy

U.S. Frozen Dessert Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Supermarkets, Hypermarkets & Mass Merchandisers
• Eateries & Specialty Shops
• Gas Stations & Convenience Stores
• Online & D2C
• Others

List of Key Players of U.S. Frozen Dessert Market

• Unilever
• Nestlé
• Froneri International Limited
• Blue Bell Creameries
• Wells Enterprises, Inc.
• Windward Brands LLC
• Tofutti Brands, Inc.
• Cold Stone Creamery, DD IP Holder LLC (Dunkin' Brands)
• Dairy Farmers of America, Inc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.